MX159034A - Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona - Google Patents

Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona

Info

Publication number
MX159034A
MX159034A MX8743A MX874385A MX159034A MX 159034 A MX159034 A MX 159034A MX 8743 A MX8743 A MX 8743A MX 874385 A MX874385 A MX 874385A MX 159034 A MX159034 A MX 159034A
Authority
MX
Mexico
Prior art keywords
benzilftalazinone
substituted derivatives
improved procedure
obtaining substituted
group
Prior art date
Application number
MX8743A
Other languages
English (en)
Spanish (es)
Inventor
Jurgen Engel
Gerhard Scheffler
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of MX159034A publication Critical patent/MX159034A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX8743A 1984-09-14 1985-09-10 Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona MX159034A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3433776 1984-09-14

Publications (1)

Publication Number Publication Date
MX159034A true MX159034A (es) 1989-04-13

Family

ID=6245402

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8743A MX159034A (es) 1984-09-14 1985-09-10 Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona

Country Status (16)

Country Link
US (1) US4704387A (enExample)
EP (1) EP0174464B1 (enExample)
JP (1) JPH0699425B2 (enExample)
AT (1) ATE49205T1 (enExample)
CA (1) CA1263652A (enExample)
DD (1) DD240205A5 (enExample)
DE (1) DE3575135D1 (enExample)
DK (1) DK167118B1 (enExample)
ES (2) ES8605509A1 (enExample)
GR (1) GR852219B (enExample)
HU (1) HU197740B (enExample)
IE (1) IE64839B1 (enExample)
IL (1) IL75989A0 (enExample)
MX (1) MX159034A (enExample)
PT (1) PT81122B (enExample)
ZA (1) ZA856524B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
ATE84968T1 (de) * 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
EP0396069B1 (de) * 1989-05-05 1994-06-22 ASTA Medica Aktiengesellschaft Salze des Azelastins mit verbesserter Löslichkeit
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP1827499A4 (en) 2004-11-24 2010-03-17 Medpointe Healthcare Inc COMPOSITIONS COMPRISING AZELASTIN AND METHODS OF USE
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
TW200811116A (en) * 2006-04-20 2008-03-01 Glaxo Group Ltd Compounds
ATE525370T1 (de) * 2007-10-11 2011-10-15 Glaxo Group Ltd Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
CH572914A5 (enExample) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones

Also Published As

Publication number Publication date
DD240205A5 (de) 1986-10-22
JPS6172782A (ja) 1986-04-14
IE64839B1 (en) 1995-09-06
EP0174464B1 (de) 1990-01-03
DK167118B1 (da) 1993-08-30
ES546971A0 (es) 1986-03-16
DK416585D0 (da) 1985-09-13
IL75989A0 (en) 1985-12-31
ES546959A0 (es) 1986-03-16
CA1263652A (en) 1989-12-05
GR852219B (enExample) 1986-01-14
ATE49205T1 (de) 1990-01-15
ES8605510A1 (es) 1986-03-16
HU197740B (en) 1989-05-29
PT81122B (pt) 1988-01-22
PT81122A (de) 1985-10-01
EP0174464A2 (de) 1986-03-19
DE3575135D1 (de) 1990-02-08
IE852270L (en) 1986-03-14
HUT38340A (en) 1986-05-28
DK416585A (da) 1986-03-15
ZA856524B (en) 1986-04-30
US4704387A (en) 1987-11-03
JPH0699425B2 (ja) 1994-12-07
EP0174464A3 (en) 1986-12-30
ES8605509A1 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
MX159034A (es) Procedimiento mejorado para obtener derivados substituidos de la benzilftalazinona
ES545771A0 (es) Un procedimiento para preparar derivados de quiniona.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES557316A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidrovalerilo.
ES546189A0 (es) Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas
ES552944A0 (es) Un procedimiento para la preparacion de derivados de tia(oxa) diazol
ES525256A0 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
SE8601646D0 (sv) Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
ES544753A0 (es) Un procedimiento para la preparacion de carbapenems.
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES539942A0 (es) Un procedimiento para la preparacion de derivados de hidantoina.
ES486422A0 (es) Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos.
ES493462A0 (es) Un procedimiento de preparacion de dihidro-2,3-dime- til-2,2-hidroxi-7-benzofurano
ES555459A0 (es) Procedimiento para preparar derivados de saframicina a.
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
ES491999A0 (es) Un procedimiento mejorado para la preparacion de compuestos de trialcoxisilanol estericamente impedidos.
ES529736A0 (es) Un procedimiento para la preparacion de 3-formil-2-nitrometilen-tetrahidro-2h-1, 3-tiazina
ES2072288T3 (es) Preparacion de enantiomeros de dropropizina.
MX5840A (es) Procedimiento para la preparacion de compuestos heterociclicos.
ES547438A0 (es) Un procedimiento para la preparacion de derivados de carbaprem.
ES550508A0 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES548044A0 (es) Un procedimiento para la preparacion de un derivado de fluorescencia.
AR240826A1 (es) Procedimiento para preparar derivados de 7beta-(2-(2-aminotiazol-4-il)2-alcoxiiminoacetamido)-3-(1-piridinometil)-3-cefem-4-carboxilato
ES512599A0 (es) "procedimiento para la obtencion de un derivado de la (1h)-6-oxo-3,4'-bipiridina".